Chia‐Ron Yang

2.0k citations

56 papers · 1.7k indexed · h-index 25

Impact in

Cancer Research top 10%
- MicroRNA in disease regulation
Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors

Papers in ⓘ

Molecular Biology 35
- Histone Deacetylase Inhibitors Research 17
- Protein Degradation and Inhibitors 6
Oncology 12
- Peptidase Inhibition and Analysis 6
- Cancer-related Molecular Pathways 4

Co-authors: Jing‐Ping Liou (18 shared papers)Wan‐Wan Lin (4 shared papers)Shie-Liang Hsieh (3 shared papers)Che‐Ming Teng (10 shared papers)Jyh‐Horng Wang (5 shared papers)Feng‐Ming Ho (2 shared papers)Hsueh‐Yun Lee (9 shared papers)Chien Chao (1 shared paper)
Journals: Biomedicine & Pharmacotherapy (5 papers)Oncotarget (3 papers)European Journal of Medicinal Chemistry (3 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (2 papers)The Journal of Immunology (2 papers)
Partner nations: Taiwan United States China

In The Last Decade

Chia‐Ron Yang

55 papers receiving 1.7k citations

Peers

Countries citing papers authored by Chia‐Ron Yang

Since Specialization

Citations

This map shows the geographic impact of Chia‐Ron Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Ron Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Ron Yang more than expected).

Fields of papers citing papers by Chia‐Ron Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Ron Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Ron Yang. The network helps show where Chia‐Ron Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Chia‐Ron Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chia‐Ron Yang Line = papers co-authored together Chia‐Ron Yang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-κB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway Cellular Signalling ·Feng Ming Ho, Wan‐Wan Lin, Bing Chang Chen, Chien Chao, Chia‐Ron Yang, Lian‐Yu Lin, Chih Chang Lai, Shing‐Hwa Liu, Yook Chin Chia	2005	218
2	Soluble Decoy Receptor 3 Induces Angiogenesis by Neutralization of TL1A, a Cytokine Belonging to Tumor Necrosis Factor Superfamily and Exhibiting Angiostatic Action Cancer Research ·Chia‐Ron Yang, Shie-Liang Hsieh, Che‐Ming Teng, Feng‐Ming Ho, Wenling Su, Wan‐Wan Lin	2004	92
3	Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes Osteoarthritis and Cartilage ·Jyh‐Horng Wang, K.S. Shih, Yiwen Wu, A. W. Wang, Chia‐Ron Yang	2013	82
4	The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model Cell Death and Disease ·Sheng-Jun Fan, Fang-I Huang, Jing‐Ping Liou, Chia‐Ron Yang	2018	81
5	Decoy Receptor 3 Increases Monocyte Adhesion to Endothelial Cells via NF-κB-Dependent Up-Regulation of Intercellular Adhesion Molecule-1, VCAM-1, and IL-8 Expression The Journal of Immunology ·Chia‐Ron Yang, Shie-Liang Hsieh, Feng‐Ming Ho, Wan‐Wan Lin	2005	77
6	Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells Cell Death and Differentiation ·Chia‐Ron Yang, Jyh‐Horng Wang, Shie-Liang Hsieh, S M Wang, Tsui-Ling Hsu, Wan‐Wan Lin	2004	75
7	(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo Journal of Medicinal Chemistry ·Hsueh‐Yun Lee, Kunal Nepali, Fang-I Huang, C.S. Chang, Mei-Jung Lai, Yu-Hsuan Li, Hsiang-Ling Huang, Chia‐Ron Yang, Jing‐Ping Liou	2018	72
8	Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-κB and JNK/p38 MAPK activation pathways Journal of Biomedical Science ·I-Ni Hsieh, Anita Shin-Yuan Chang, Che‐Ming Teng, Chien‐Chih Chen, Chia‐Ron Yang	2011	60
9	5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer’s Disease Phenotypes Journal of Medicinal Chemistry ·Hsueh‐Yun Lee, Sheng-Jun Fan, Fang-I Huang, Hsin-Yi Chao, Kai‐Cheng Hsu, Tony Eight Lin, Teng-Kuang Yeh, Mei-Jung Lai, Yu-Hsuan Li, Hsiang-Ling Huang, Chia‐Ron Yang, Jing‐Ping Liou	2018	57
10	Denbinobin upregulates miR-146a expression and attenuates IL-1β-induced upregulation of ICAM-1 and VCAM-1 expressions in osteoarthritis fibroblast-like synoviocytes Journal of Molecular Medicine ·Chia‐Ron Yang, Kao‐Shang Shih, Jing‐Ping Liou, Yiwen Wu, I-Ni Hsieh, Hsueh‐Yun Lee, Tzu-Cheng Lin, Jyh‐Horng Wang	2014	47
11	Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity European Journal of Medicinal Chemistry ·Samir Mehndiratta, Yi-Ling Hsieh, Yi-Min Liu, Amber Weiching Wang, Hsueh‐Yun Lee, Lung-Yu Liang, Sunil Kumar, Che‐Ming Teng, Chia‐Ron Yang, Jing‐Ping Liou	2014	43
12	3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity European Journal of Medicinal Chemistry ·Hsueh‐Yun Lee, Jiann-Fong Lee, Sunil Kumar, Yi-Wen Wu, Wei‐Chun HuangFu, Mei-Jung Lai, Yu-Hsuan Li, Hsiang-Ling Huang, Fei-Chiao Kuo, Che-Jen Hsiao, Chun-Chun Cheng, Chia‐Ron Yang, Jing‐Ping Liou	2016	40
13	Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity International Journal of Molecular Sciences ·Ching-Hsuan Chou, Chia‐Ron Yang	2021	40
14	Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease Journal of Neuroscience Research ·Chia‐Ron Yang, Robert K. Yu	2008	37
15	An EGFR wild type–EGFRvIII–HB-EGF feed-forward loop regulates the activation of EGFRvIII Oncogene ·L Li, Sharmistha Chakraborty, Chia‐Ron Yang, Kimmo J. Hatanpaa, Daisha J. Cipher, Vineshkumar Thidil Puliyappadamba, Asad Ur Rehman, Ameena J Jiwani, Bruce Mickey, Christopher Madden, Jack Raisanen, Sandeep Burma, Debabrata Saha, Zheng Wang, Sandeep C. Pingle, Santosh Kesari, David A. Boothman, Amyn A. Habib	2013	35
16	Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Yi-Ling Hsieh, Huang‐Ju Tu, Shiow‐Lin Pan, Jing‐Ping Liou, Chia‐Ron Yang	2019	35
17	2-(Phenylsulfonyl)quinoline N -hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase European Journal of Medicinal Chemistry ·Hsueh‐Yun Lee, C.S. Chang, Chih-Jou Su, Han-Li Huang, Samir Mehndiratta, Yuh-Hsuan Chao, Chia‐Ming Hsu, Sunil Kumar, Ting-Yi Sung, Yi-Zhen Huang, Yu-Hsuan Li, Chia‐Ron Yang, Jing‐Ping Liou	2016	32
18	Decoy Receptor 3 Expression in AsPC-1 Human Pancreatic Adenocarcinoma Cells via the Phosphatidylinositol 3-Kinase-, Akt-, and NF-κB-Dependent Pathway The Journal of Immunology ·Pei-Hsuan Chen, Chia‐Ron Yang	2008	32
19	Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009 Cell Death and Disease ·I-Ni Hsieh, J-P Liou, H. Y. LEE, M. H. Lai, Y-H Li, Chia‐Ron Yang	2014	30
20	Unsuspected Prostate Carcinoma and Prostatic Intraepithelial Neoplasm in Taiwanese Patients Undergoing Cystoprostatectomy. PubMed ·Chia‐Ron Yang, YC Ou, HC Ho, YL Kao, CL Cheng, JT Chen, LP Chen, WL Ho	1999	30

About Chia‐Ron Yang

Chia‐Ron Yang is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Cancer Research, having authored 56 papers that have together received 1.7k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (17 papers), Protein Degradation and Inhibitors (6 papers), Peptidase Inhibition and Analysis (6 papers), Computational Drug Discovery Methods (5 papers), Alzheimer's disease research and treatments (4 papers), Cancer-related Molecular Pathways (4 papers), Immune Response and Inflammation (4 papers) and Biological and pharmacological studies of plants (4 papers). The work is most often cited by research in Cancer Research (230 citations), Molecular Biology (1.0k citations), Pharmacology (219 citations), Immunology (263 citations) and Oncology (316 citations). Chia‐Ron Yang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Jing‐Ping Liou, Wan‐Wan Lin, Shie-Liang Hsieh, Che‐Ming Teng, Jyh‐Horng Wang, Feng‐Ming Ho, Hsueh‐Yun Lee, Chien Chao, Yiwen Wu and Shing‐Hwa Liu. Their work appears in journals such as Biomedicine & Pharmacotherapy, Oncotarget, European Journal of Medicinal Chemistry, Journal of Enzyme Inhibition and Medicinal Chemistry and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact